Alzheimer's disease

Alzheimer's drug development just as challenging as ever
BioPharma Dive
Thu, 09/21/17 - 10:11 pm
drug development
Alzheimer's disease
PhRMA
Duchenne muscular dystrophy
Motley Fool
Thu, 09/21/17 - 10:10 pm
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
Xconomy
Mon, 09/18/17 - 09:43 am
Rodin Therapeutics
Biogen
Alzheimer's disease
clinical trials
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Stat
Thu, 09/7/17 - 09:35 am
Alzheimer's disease
Axovant
David Hung
dimebon
Medivation
intepirdine
Upcoming events – GSK’s shingles panel and Axovant takes on Alzheimer’s
EP Vantage
Sat, 08/26/17 - 07:46 pm
GSK
shingles
vaccines
Shingrix
Axovant
Alzheimer's disease
intepirdine
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
GoInPharma
Thu, 08/17/17 - 11:47 pm
Biogen
Alzheimer's disease
aducanumab
New target could yield treatment for Alzheimer's, ALS and more
Fierce Biotech
Thu, 08/17/17 - 09:57 am
Genentech
Roche
drug development
R&D
Alzheimer's disease
ALS
Neurotrope stock tumbles again on Alzheimer's data
BioPharma Dive
Thu, 07/20/17 - 11:14 am
Neurotrope BioScience
Alzheimer's disease
New data from Alzheon shows long-term benefit for Alzheimer's
BioPharma Dive
Tue, 07/18/17 - 11:33 am
Alzheon
Alzheimer's disease
ALZ-801
5 trends shaping Alzheimer's drug development
BioPharma Dive
Tue, 07/18/17 - 09:23 am
Alzheimer's disease
drug development
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Endpoints
Fri, 07/14/17 - 08:12 am
Big Pharma
venture capital
Alzheimer's disease
Alzheon says data backs potential of Alzheimer's candidate
PM Live
Fri, 06/23/17 - 03:34 pm
Alzheon
Alzheimer's disease
tramiprosate
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Alzheimer's disease
anti-amyloid
solanezumab
Eli Lilly
Biogen
aducanumab
RVT-101
Alzheimer's Affects Twice As Many People As Estimated, Says New Study
Forbes
Thu, 06/15/17 - 02:39 pm
Alzheimer's disease
In small Alzheimer’s study, hints of modest benefit from unusual drug
Stat
Mon, 05/1/17 - 11:35 am
Alzheimer's disease
Neurotrope BioScience
Bryostatin-1
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
FOX Business
Sat, 04/22/17 - 01:12 pm
Novartis
Alzheimer's disease
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
Yahoo/Business Insider
Mon, 04/10/17 - 10:12 pm
Alzheimer's disease
David Hung
Pharma CEOs
Axovant Sciences
Alzheimer's $250B Cost Could Break Medicare
Forbes
Tue, 03/7/17 - 11:16 am
Alzheimer's disease
Medicare
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Endpoints
Tue, 03/7/17 - 10:29 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Thu, 03/2/17 - 10:16 am
Alzheimer's disease
drug development
Roche
Merck
Eli Lilly
Biogen

Pages